Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Testing Status of Allyl bromide M950093

 

CASRN: 106-95-6

Formula: C3-H5-Br

Synonyms/Common Names

  • AB
  • 3-Bromopropene
  • 3-Bromopropylene
  • 1-Propene, 3-bromo-
  • 2-Propenyl bromide

Short-Term Toxicity

  • 2 weeks (Gavage)  (C96003)  Completed 
    • Mice: C57BL/6
    • Dose: 0, 7.5, 15, 30, 60, OR 120 MG/KG; 5/SEX/DOSE; 5X/WEEK.
  • 2 weeks (Topical Application)  (C96003B)  Completed 
    • Mice: FVB/N
    • Dose: 0, 7.5, 15, 30, 60 OR 120 MG/KG; 5/SEX/DOSE; 5X/WEEK.
  • 40 weeks (Gavage)  (C96003)  Completed 
    • GMM-07 (NIH Number: 08-4424)  (Peer Review Approval 08/28/2006A )
      Toxicology Studies of Allyl Bromide (CASRN 106-95-6) in Genetically Modified (FVB Tg.AC Hemizygous) Mice and Carcinogenicity Studies of Allyl Bromide in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Dermal and Gavage Studies)
    • Mice: C57BL/6; Mice: P53 +/- (C57BL/6)
    • Carcinogenesis Results
      • Male No Evidence 
      • Female No Evidence 
    • Dose: P53: 0, 0.5, 1, 2, 4 OR 8 MG/KG; 15/SEX/DOSE C57BL/6: 0 OR 8 MG/KG; 15/SEX/DOSE.
  • 40 weeks (Gavage)  (C96003C)  Completed 
    • GMM-07 (NIH Number: 08-4424)  (Peer Review Approval 08/28/2006A )
      Toxicology Studies of Allyl Bromide (CASRN 106-95-6) in Genetically Modified (FVB Tg.AC Hemizygous) Mice and Carcinogenicity Studies of Allyl Bromide in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Dermal and Gavage Studies)
    • Mice: FVB/N; Mice: Tg.AC (FVB/N) Hemizygous
    • Carcinogenesis Results
      • Male No Evidence 
      • Female No Evidence 
    • Dose: TG.AC: 0, 0.5, 1, 2, 4, OR 8 MG/KG; 15/SEX/DOSE FVB/N: 0 OR 8 MG/KG; 15/SEX/DOSE.

Special Studies

  • Toxicokinetic Study (in-vitro)  (S0667)  Completed 
    • Rats: F344/N

Genetic Toxicology

  • Micronucleus  (A03068)  Completed 
    • Mice: Tg.AC
    • Male Negative 
    • Female Negative 
  • Micronucleus  (A27120)  Completed 
    • Mice: FVB/N
    • Male Negative 
    • Female Negative 
  • Micronucleus  (A43640)  Completed 
    • Mice: P53 +/- (C57BL/6)
    • Male Negative 
    • Female Negative 
  • Micronucleus  (A87628)  Completed 
    • Mice: C57BL/6
    • Male Negative 
    • Female Negative 
  • Salmonella  (A92510)  Completed 
    •  Positive